The global mitral valve disease market was valued at USD 3.2 billion in 2023, growing at a CAGR of 9.1% from 2024 to 2033. The market is expected to reach USD 7.6 billion by 2033. The market is driven by the increasing incidence of cardiovascular disorders, specifically mitral valve disease. The ageing population, poor diets, and sedentary lifestyles all contribute to the condition's rising prevalence.
Any illness that affects the structure or operation of the mitral valve, one of the four valves of the human heart, is referred to as mitral valve disease. The valve controls how much blood flows from the atrium to the ventricle and is between the left and left ventricles. The market is driven by the increasing incidence of cardiovascular disorders, specifically mitral valve disease. The ageing population, poor diets, and sedentary lifestyles all contribute to the condition's rising prevalence. Innovative imaging methods and minimally invasive surgical alternatives are two examples of how medical technology advancements have enhanced diagnosis and treatment. Regular check-ups and greater knowledge about cardiovascular health encourage early identification and intervention, which enhances patient outcomes. Given that age increases the likelihood of mitral valve disease, the ageing population is a major factor.
Get an overview of this study by requesting a free sample
In January 2020, The Tendyne Transcatheter Mitral Valve Implantation (TMVI) system, which treats mitral regurgitation (MR) in patients in need of heart valve replacement, was given the CE Mark clearance by Abbott and is now authorized for use in Europe.
In September 2021, The Food and Drug Administration (FDA) in the United States approved Abbott's market of Epic Plus and Epic Plus Supra Stented Tissue Valves. The therapy choices for patients with aortic or mitral valve disease are enhanced by these new devices built on Abbott's Epic surgical valve platform.
In June 2021, Gyrus Capital acquired the heart valve division of LivaNova Plc., and Corcym announced the commencement of its activities worldwide. The newly established, independent medical device company aims to give patients and cardiac surgeons the finest tools possible to combat structural heart disease.
In March 2019, Edwards Lifesciences Corporation disclosed two strategic transactions involving firms with structural heart disease technology. A $35 million investment is made in the exclusive right to purchase Corvia Medical, Inc., as well as some of the assets of Mitralign, Inc. This business creates medical devices to treat mitral valve regurgitation.
In November 2021, Using the transfemoral access method, Medtronic plc. Provided early data for the Intrepid transcatheter mitral valve replacement (TMVR) system in patients with severe, symptomatic mitral valve regurgitation (MR). According to data from the first five patients in the Intrepid Transfemoral System Early Feasibility Study, all implanted patients had either no or trace MR at 30 days, 100% survival, and no stroke.
Rising awareness- Increased patient screening efforts, early diagnosis programmes, and awareness campaigns contribute to the early identification and timely treatment of mitral valve illnesses, which benefits the market. Proactively addressing early diagnosis by healthcare practitioners increases the likelihood of effective therapies and benefits the general health of their patients.
Regulatory challenges- Strict regulatory approval procedures for medical treatments and technologies can raise development costs and cause market entry delays. Therapies for mitral valve disease must adhere to stringent regulatory requirements, and delays or rejections may impact product launches and market expansion.
Increasing technological advancement- Treatment outcomes are improved, and patients and healthcare professionals are drawn to the latest advancements in medical technology and surgical techniques, such as transcatheter mitral valve repair and minimally invasive treatments. Continuous research and development endeavours enhance patient care by broadening the range of available treatments.
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. North America emerged as the largest global mitral valve disease market, with a 42.1% market revenue share in 2023.
North America's strong infrastructure for cutting-edge biotechnology and healthcare research and development accounts for a large portion of the market for mitral valve disease. This is mainly due to the region's growing frequency of mitral valve illnesses, a well-developed healthcare system, and increased consumer awareness of these conditions. Furthermore, the prevalence of mitral valve goods among North American consumers is rising due to the key manufacturers' presence in the country and their extensive offering in the mitral valve treatment sector.
North America Region Mitral Valve Disease Market Share in 2023 - 42.1%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
The treatment type segment is divided into mitral valve replacement, mitral valve therapeutics, mitral valve repair, and cardiac resynchronization therapy. The mitral valve repair segment dominated the market, with a market share of around 37% in 2023. The segment's growth is explained by the benefits of the repair process, which include quicker healing and the maintenance of the natural valve. The patient can preserve their natural heart valve because the repaired mitral valve works better and doesn't require lifetime anticoagulants. Compared to replacement, this technique is less intrusive, which results in a quicker recovery and less pain for the patient.
The indication segment is divided into mitral valve prolapse, mitral valve regurgitation, and mitral valve stenosis. The mitral valve regurgitation segment dominated the market, with a market share of around 46% in 2023. The development of sophisticated mitral valve devices by major companies for the treatment of mitral regurgitation and an increase in the incidence of mitral prolapse, which causes mitral regurgitation, are credited with the expansion of the mitral valve regurgitation segment.
The end-user segment is divided into ambulatory surgical centres, hospitals, and others. The hospital segment dominated the market, with a market share of around 48% in 2023. Since most mitral valve replacement and repair procedures are performed in hospitals, highly skilled personnel specializing in cardiac surgery can lower the risk of complications during and after surgery. Thereby supporting the expansion of the hospital segment.
Report Description:
Attribute | Description |
---|---|
Market Size | Revenue (USD Billion) |
Market size value in 2023 | USD 3.2 Billion |
Market size value in 2033 | USD 7.6 Billion |
CAGR (2024 to 2033) | 9.1% |
Historical data | 2020-2022 |
Base Year | 2023 |
Forecast | 2024-2033 |
Region | The regions analyzed for the market are Asia Pacific, Europe, South America, North America, and Middle East & Africa. Furthermore, the regions are further analyzed at the country level. |
Segments | Treatment Type, Indication, End-User |
As per The Brainy Insights, the size of the mitral valve disease market was valued at USD 3.2 billion in 2023 to USD 7.6 billion by 2033.
The global mitral valve disease market is growing at a CAGR of 9.1% during the forecast period 2024-2033.
North America emerged as the largest mitral valve disease market.
This study forecasts global, regional, and country revenue from 2020 to 2033. The Brainy Insights has segmented the global mitral valve disease market based on the below-mentioned segments:
Global Mitral Valve Disease Market By Treatment Type:
Global Mitral Valve Disease Market By Indication:
Global Mitral Valve Disease Market By End-User:
Global Mitral Valve Disease Market By Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date